Retrobulbar T cells from patients with Graves' ophthalmopathy are CD8+ and specifically recognize autologous fibroblasts

Journal of Clinical Investigation

Volumn 93, Issue 6, 1994, Pages 2738-2743

  Grubeck Loebenstein, B ^a   Trieb, K ^a   Sztankay, A ^a   Holter, W ^c   Anderl, H ^b   Wick, G ^a,d  

^a ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

^b UNIVERSITY OF INNSBRUCK   (Austria)

^c Vienna International Research Cooperation Center   (Austria)

^d INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

cytokines; fibroblasts; Graves' disease; ophthalmopathy; T lymphocytes

Indexed keywords

ALLOANTIGEN; AUTOANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; HLA ANTIGEN CLASS 1; INTERLEUKIN 10; INTERLEUKIN 4; TISSUE EXTRACT; TUBERCULIN;

ADULT; ALLOGENEIC RESTRICTION; ANTIGEN RECOGNITION; ARTICLE; CELL LINE; CONTROLLED STUDY; CYTOTOXICITY; ENDOCRINE OPHTHALMOPATHY; EXTRAOCULAR MUSCLE; FEMALE; FIBROBLAST; GRAVES DISEASE; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; MALE; MONONUCLEAR CELL; MYCOBACTERIUM TUBERCULOSIS; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

EID: 0028263893     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI117289     Document Type: Article

References (40)

1. Gorman, C. A., R. S. Bahn, and J. A. Garrity. 1991. Ophthalmopathy. In The Thyroid. L. E. Braverman and R. D. Utiger, editors. J. B. Lippineott Co., Philadelphia. 657-676.
2. Fells, P. 1991. Thyroid-associated eye disease: clinical management. Lancet. 338:29-32.
3. Weetman, A. P. 1991. Thyroid-associated eye disease: pathophysiology. Lancet. 338:25-28.
4. Heufelder, A. E., and R. S. Bahn. 1993. Detection and localization of cytokine immunoreactivity in retro-ocular connective tissue in Graves' ophthalmopathy. Eur. J. Clin. Invest. 23:10-17.
5. Weetman, A. P., S. Cohen, K. C. Gatter, P. Fells, and B. Shine. 1989. Immunohistochemical analysis of the retrobulbar tissues in Graves' ophthalmopathy. Clin. Exp. Immunol. 75:222-227.
6. Kroll, A. J., and T. Kuwabara. 1966. Dysthyroid ocular myopathy. Arch Ophthalmol 27:244-249.
7. Hufnagl, T. J., W. F. Hickey, N. H. Cobbs, F. A. Jacobiec, T. Iwamo, and R. C. Eagle. 1984. Immunohistochemical and ultrastructural studies on the exenterated orbital tissues of a patient with Graves' disease. Ophthalmology. 94:1411-1417.
8. Falconer, M. A., and W. S. Alexander. 1951. Experiences with malignant exophthalmus. Br. J. Ophthalmol. 35:253-259.
9. Campbell, J. C. 1989. Immunology of Graves' ophthalmopathy: retrobulbar histology and histochemistry. Acta Endocrinol. 121 (Suppl.):9-16.
10. Kodama, K., H. Sikorska, P. Bandy-Dafoe, R. Bayly, and J. R. Wall. 1982. Demonstration of a circulating autoantibody against a soluble eye-muscle antigen in Graves' ophthalmopathy. Lancet, ii:1353-1356.
11. Atkinson, S., M. Holcombe, and P. Kendall-Taylor. 1984. Ophthalmopathic immunoglobulin in patients with Graves' ophthalmopathy. Lancet. ii:374-376.
12. Kadlubowski, M., W. J. Irvine, and A. C. Rowland. 1987. Anti-muscle antibodies in Graves' ophthalmopathy. J. Clin. Lab. Immunol. 24:105-111.
13. Bahn, R. S., T. J. Smith, and C. A. Gorman. 1989. The central role of fibroblasts in the pathogenesis of extrathyroidal manifestations of Graves' disease. Acta Endocrinol. 121:75-81.
14. Bahn, R. S., C. A. Gorman, C. M. Johnson, and T. J. Smith. 1989. Presence of antibodies in the sera of patients with Graves' disease recognizing a 23 kilodalton fibroblast protein. J. Clin. Endocrinol. & Metab. 69:622-628.
15. Salvi, M., A. Miller, and J. R. Wall. 1988. Human orbital tissue and thyroid membranes express a 64 kDa protein which is recognized by autoantibodiesin the serum of patients with thyroid-associated ophthalmopathy. FEBS(Fed. Eur Biochem Soc.) Lett. 232:135-139.
16. Rotella, C. M., R. Zonefrati, R. Toccafondi, W. A. Valente, and L. D. Kohn. 1986. Ability of monoclonal antibodies to the thyrotropin receptor to increase collagen synthesis in human fibroblasts: an assay which appears to measure exophthalmogenic immunoglobulins in Graves' sera. J. Clin. Endocrinol. & Metab. 62:357-367.
17. Heufelder, A. E., C. A. Gorman, and R. S. Bahn. 1991. Modulation of HLA-DR expression on retroocular fibroblasts from patients with active thyroid-related ophthalmopathy: in vitro effects of agents used in the management of hyperthyroidism and ophthalmopathy. J. Clin. Endocrinol. & Metab. 97:206-209.
18. Heufelder, A. E., B. J. Wenzel, C. A. German, and R. S. Bahn. 1991. Detection, cellular localization, and modulation of heat shock proteins in cultured fibroblasts from patients with extrathyroidal manifestations of Graves' disease. J. Clin. Endocrinol. & Metab. 73:739-745.
19. Grubeck-Loebenstein, B., M. Londei, C. Greenall, K. Pinch, H. Kassal, W. Waldhäusl, and M. Feldmann. 1988. Pathogenetic relevance of HLA class II expressing thyroid follicular cells in nontoxic goiter and in Graves' disease. J. Clin. Invest. 81:1608-1614.
20. Trieb, K., A. Sztankay, M. Hermann, R. Gratzl, J. Szabo, S. Jindal, and B. Grubeck-Loebenstein. 1993. Do heat shock proteins play a role in Graves' disease? Heat shock protein specific T cells do not recognize thyroid epithelial cells. J. Clin. Endocrinol. & Metab. 77:528-535.
21. de Carli, M., M. D'Elios, S. Mariotti, C. Marcocci, A. Pinchera, M. Ricci, S. Romagnani, and G. del Prete. 1993. Cytolytic T cells with Th1-like cytokine profile predominate in retroorbital lymphocytic infiltrates of Graves' ophthalmopathy. J. Clin. Endocrinol. & Metab. 77:1120-1124.
22. Weetman, A. P., P. Fells, and B. Shine. 1989. T and B cell reactivity to extraocular and skeletal muscle in Graves' ophthalmopathy. Br. J. Ophthalmol. 73:323-331.
23. Munro, R. E., L. Lamki, V. V. Row, and B. Volpé. 1973. Cell-mediated immunity in the exophthalmus of Graves' disease as demonstrated by the migration inhibitor factor (MIF) test. J. Clin. Endocrinol. & Metab. 37:286-292.
24. Londei, M., B. Grubeck-Loebenstein, P. de Berardinis, C. Greenall, and M. Feldmann. 1988. Efficient propagation and cloning of human T cells in the absence of antigen by means of OKT3, interleukin 2, and antigen-presenting cells. Scand. J. Immunol. 27:35-46.
25. Holter, W., O. Majdic, F. S. Kalthoff, and W. Knapp. 1992. Regulation of interleukin-4 production in human mononuclear cells. Eur. J. Immunol. 22:2765-2769.
26. Grubeck-Loebenstein, B., K. Derfler, H. Kassal, W. Knapp, K. Krisch, K. Liszka, P. P. A. Smyth, and W. Waldhäusl. 1985. Immunological features of nonimmunogenic hyperthyroidism. J. Clin. Endocrinol & Metab. 60:150-157.
27. Maggi, E., G. F. del Prete, D. Macchia, P. Parronchi, A. Tiri, I. Chretien, M. Ricci, and S. Romagnani. 1988. Profiles of iymphokine activities and helper function for IgE in human T cell clones. Eur. J. Immunol. 18:1045-1051.
28. Romagnani, R. 1992. Human Th1 and Th2 subsets: regulation of differon and role in protection and immunopathology. Int. Arch. Allergy Immunol. 98:279-284.
29. Salgame, P., J. S. Abrams, C. Clayberger, H. Goldstein, J. Convitt, R. L. Modlin, and B. R. Bloom. 1991. Differing lymphokine profiles and functional subsets of human CD4 and CD8 T cell clones. Science (Wash. DC). 254:279-285.
30. Spits, H., and R. de Waal Malefyt. 1992. Functional characterization of human IL-10. Int. Arch. Allergy Immunol. 99:8-15.
31. Hsu, D. H., K. W. Moore, and H. Spits. 1992. Differential effects of interleukin-4 and-10 on IL-2 induced interferon-γ synthesis and lymphokine-activated killer activity. Int. Immunol. 4:563-569.
32. de Waal Malefyt, R., J. Haanen, H. Spits, M.-G. Roncarolo, A. te Velde, C. Figdor, K. Johnson, R. Kastelein, H. Yssel, and J. E. de Vries. 1991. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J. Exp. Med. 174:915-924.
33. Smith, T. J., R. S. Bahn, and C. A. Gorman. 1991. Stimulation of glycosaminoglycan accumulation by interferon-gamma in cultured human retrocular fibroblasts. J. Clin. Endocrinol. & Metab. 72:1169-1174.
34. Hopwood, J. J., and A. Dorfmann. 1977. Glycosaminoglycan synthesis by cultured human skin fibroblasts after transformation with simian virus 40. J. Biol. Chem. 252:4777-4783.
35. Ciampolillo, A., V. Marini, R. Mirakian, M. Buscema, T. Schulz, R. Pujol-Borell, and G. F. Bottazzo. 1989. Retrovirus-like sequences in Graves' disease: implications for human autoimmunity. Lancet. i:1096-1099.
36. Lagaye, S., P. Vexiau, V. Morozov, F. Saal, J. Gony. A. Poorters, V. Loosfeld-Poirot, J. Hors, G. Cathelineao, R. Emanoil-Ravier, and J. Peries. 1991. Detection of HTLV-I gag related sequence in leukocyte DNA from patients with polyendocrinopathies (Basedow-Graves' disease and insulin-dependent diabetes). Compt. Rend. Acad. Sci. Paris. 312:309-315.
37. Kawai, H., M. Saito, M. Takagi, T. Tsuchihashi, Y. Arii, A. Kondo, M. Iwasa, T. Hirose, K. Hizawa, and S. Saito. 1992. Hashimoto's thyroiditis in HTLV-1 carriers. Intern. Med. 31:1213-1216.
38. Tas, M., M. de Haan-Meulman, P. J. Kabel, and H. A. Drexhage. 1991. Defects in monocyte polarization and dendritic cell clustering in patients with Graves' disease. A putative role for a non-specific immunoregulatory factor related to retroviral p15E. Clin. Endocrinol 34:441-449.
39. Wick, G., B. Grubeck-Loebenstein, K. Trieb, G. Kalischnig, and A. Aguzzi. 1992. Human foamy virus antigens in thyroid tissue of Graves' disease patients. Int. Arch. Allergy Immunol. 99:153-156.
40. Wick, G., K. Trieb, A. Aguzzi, H. Recheis, H. Anderl, and B. Grubeck-Loebenstein. 1993. Possible role of human foamy virus in Graves' disease. Intervirology. 35:101-112.